ORAGENICS INC (OGEN)
US6840235005 - Common Stock
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. Files 10K and Provides Company Update
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Oragenics Announces Closing of Public Offering
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.
Why Is Integral Ad Science (IAS) Stock Down 29% Today?
Integral Ad Science stock is falling on Wednesday as IAS investors are unimpressed by the company's outlook in its latest earnings report.
Why Is Oragenics (OGEN) Stock Down 45% Today?
Oragenics stock is falling on Wednesday as investors in OGEN react to the pricing of a public offering for the company's shares.
Oragenics stock dips after pricing $2.1M stock offering (NYSE:OGEN)
Oragenics' shares plummet 44% as the pharmaceutical company prices a stock offering to raise $2.1M for the development of a neurosteroid drug to treat...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we're starting this morning with a breakdown of all the biggest news moving shares!
Oragenics Announces Pricing of Public Offering
Oragenics to sell shares in a public offering (NYSE:OGEN)
Oragenics announces proposed public offering, offering shares for sale and granting underwriters an option to purchase additional shares.
Oragenics Announces Proposed Public Offering
Oragenics says CEO Murphy steps down from the role (NYSE:OGEN)
Oragenics (OGEN) announced CEO Kimberly Murphy's departure following a separation agreement.
Oragenics, Inc. Announces Leadership Transition
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!
Oragenics terminates ATM offering program; shares jump (NYSE:OGEN)
Oragenics (NYSE:OGEN) said Tuesday it has terminated its previously announced at-the-market equity offering program.The termination is expected to take...
Oragenics Announces Termination of At-The-Market Offering Program
Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets
Oragenics Issues Update to Shareholders
Oragenics Announces Appointment of Bruce Cassidy and John Gandolfo to Board of Directors
Oragenics to acquire certain assets of Odyssey Health (NYSE:OGEN)
Oragenics acquires Odyssey Health's neurological drug therapies and technologies assets, including treatments for brain injury and Niemann Pick Disease Type...
